TB Alliance: Putting science to work for a faster TB cure

Donate

News Center

Potential new weapon in TB drug arsenal

The first promising tuberculosis (TB) drug in almost 40 years could be the most potent yet and also treat the disease faster, according to research pu...

12/10/2004Press CoverageContinue Reading >

Antibiotic is better drug for TB

Scientists believe they have found a tuberculosis (TB) drug that could succeed where others are failing. Although it is still at a very early stag...

12/10/2004Press CoverageContinue Reading >

TB Drug Pipeline Includes New Candidate from Johnson & Johnson

The TB Alliance is pleased to welcome Johnson & Johnson to the select group of companies and organizations working diligently on new drugs to fi...

12/09/2004Continue Reading >

Compound J tackles tuberculosis

Next generation of drugs perform well against resistant strains. Tuberculosis kills 2 million people a year, but a promising drug may save...

12/09/2004Press CoverageContinue Reading >

Trapping the Superbugs

Nicholas Johnson nearly died from what he thought was a shoulder sprain. Last year the 13-year-old from Stafford, Texas, made an awkward tackle in foo...

12/06/2004Press CoverageContinue Reading >

World AIDS Day 2004: New TB Drugs Essential in Fight Against AIDS

“It's time for TB patients to push for action on the research side. We need to say, 'Look, we are here, and we need new drugs and treatm...

12/01/2004Continue Reading >

Report by the World Health Organization on �Priority Medicines for Europe and the World�

World Health Organization (WHO): “Priority Medicines for Europe and the World” This report, launched at the conference on “P...

11/18/2004Continue Reading >

Joelle Tanguy Assumes New Post at Global Business Coalition on HIV/AIDS (GBC)

After three and a half years of dedicated service as the Director of Advocacy and Public Affairs at the TB Alliance, Joelle Tanguy begins a new ventur...

11/17/2004Continue Reading >

In Memoriam: Dr. John R. La Montagne

IN MEMORIAMJohn R. La Montagne, Ph.D.,NIAID Deputy DirectorSecretary, TB Alliance Board of Directors1943 - 2004 Dr. John La Montagne, deputy direct...

11/04/2004Continue Reading >

Collaboration aims to produce non-profit TB drugs

[SINGAPORE] The Novartis Institute for Tropical Diseases (NITD) and the Global Alliance for Tuberculosis Drug Development (TB Alliance) have announced...

11/04/2004Press CoverageContinue Reading >